ArticleMolecular cancer2017

Vasohibin 2 reduces chemosensitivity to gemcitabine in pancreatic cancer cells via Jun proto-oncogene dependent transactivation of ribonucleotide reductase regulatory subunit M2.

Min Tu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.